A total of 80 menstruating rhesus monkeys {Macaca mulatta) were equally and randomly divided among groups receiving 0, 5, 20, 40, or 80 fig of Aroclor 1254/kg body weight/day during a 6-year toxicological-reproduction study. During the first 3 years of the study, 4 of the treated monkeys became moribund and were euthanized; 3 had endometriosis. This finding suggested a possible link between the PCB treatment and the occurrence of endometriosis. However, neither a laparoscopic examination of the control and high-dose monkeys nor the necropsy data provided evidence for a possible link between the PCB treatment and the observed incidence (37% (6/16) of controls; 25% (16/64) of treated monkeys and/or the severity of the endometrial lesions. Additional clinical and historical data not contained in previous reports are presented to facilitate independent evaluation of the relationship between PCB ingestion and endometriosis. We conclude that the incidence and severity of the endometriosis lesions observed in the rhesus monkeys utilized in this study did not have any relationship with the dosages of Aroclor 1254 they ingested. © 1996 Society of Toxi col ogy Endometriosis, the ectopic growth of endometrial tissue outside of the uterus, is an enigmatic gynecologic disease (Adamson, 1990; Olive and Schwartz, 1993; Thomas, 1993) that is often associated with infertility, pelvic pain, and adhesions (Damewood, 1989; Galle, 1989; Adamson, 1990; Schweppe, 1990; Thomas, 1991; Brosens, 1992; Olive and Schwartz, 1993) . It is not a "new" disease, having been reported as early as 1600 B.C. in women (Ebers, 1873) and recently in rhesus monkeys (Fraser, 1929) . Endometriosis transcends the clinico-pathologic distinction between a benign disease and an invasive neoplasm. Histologically benign, endometriosis has been found to invade local pelvic structures (Raible, 1981; Martin, 1988; Koninckx and Martin, 1992; Bergqvist, 1993) and metastasize to extraperitoneal sites (Wheeler and Malinak, 1987) . However, some contend that the distal implantation of endometrial glands is such a rarely documented event there is concern that such situations may not be endometriosis as it is currently understood (personal communication, D. C. Martin, 1995) . Recent developments in the understanding of the pathogenesis and pathophysiology of endometriosis have lead some to question whether endometriosis should still be considered a disease (Wardle and Hull, 1993) .
The monkey is probably the most suitable animal model for studying endometriosis, as they and women have similar endocrinological and menstrual cycles (Hodgen et ah, 1977; Schenken et al, 1991; Walker, 1995) as well as display similar clinical (MacKenzie and Casey, 1975; Swenson, 1993) and histological manifestations Sternfeld et al, 1988) . The rhesus monkey is the most intensively studied member of its species in this regard. While spontaneous endometriosis has been reported (Fraser, 1929; Krohn, 1951; Scott et al., 1953; McCann and Meyers, 1970; Davis, 1987; Howard et al., 1989; Saegusa, 1990; Fanton and Golden, 1991; Moody et al, 1991) , it has also been suggested that there is a relationship between endometriosis in the rhesus monkey and a variety of conditions including the following: (1) surgery to the uterus (Hartman, 1944; Pickering, 1968; McCann and Myers, 1970; DiGiacomo, 1977; Bertens et al, 1982) ; (2) parity (McCann and Myers, 1970; DiGiacomo, 1977) ; (3) irradiation (Eisenfeld etal, 1971; McClure etal, 1969 McClure etal, , 1971 Splitter et al, 1972; McClure, 1979; Bertens et al, 1982; Wood et al, 1983; Fanton and Wood, 1986; Fanton and Golden, 1991; Wood, 1991) ; (4) estrogen treatment (Vadova and Smoilovskaya, 1957; Bertens et al, 1982; Lindberg and Busch, 1984) ; (5) number of matings (DiGiacomo, 1977) ; (6) cell-mediated immune deficiency (Dmowski et al, 1981; Rier et al, 1993b) ; (7) age and time since last pregnancy (McCann and Myers, 1970; DiGiacomo, 1977; Saegusa, 1990; Fanton and Golden, 1991) ; (8) husbandry practices (DiGiacomo, 1977) ; (9) vitamin D (Saegusa, 1990) ; (10) endocrine imbalance (Kliiver and Bartelmez, 1951); and/or (11) exposure to 2,3,7,8-tetrachloro-p-dioxin (TCDD; Rier et al, 1993a) .
Clinical studies have indicated a relationship between endometriosis and deficiencies in humoral and cell-mediated immunity, a reduction in total hemolytic complement activity, as well as deposition of C 3 , IgG, and IgA in the uterine endometrium (Weed and Arquembourg, 1980; Saifuddin et al, 1983; Badawy et al, 1984; Wild and Shivers, 1985; Kreiner et al, 1986) . A higher incidence of autoantibodies against ovarian and endometrial tissues (Wild and Shivers, 1985; Gleicher et al, 1987) and against several antigens including phosphatidyl serine, histones, and nucleotides has also been detected in women with endometriosis, indicating polyclonal B-cell activation (Startseva, 1980; Gleicher et al, 1987; El-Roeiy et al, 1988) . Functional aspects of the mononuclear phagocytic lineage of cells have also been investigated in women with endometriosis (Dmowski et al, 1981) . These studies demonstrated that peripheral blood monocytes stimulated with phorbol myristate acetate or serum-opsonized zymosan had significantly higher chemiluminescence activity and higher production of EL-1 in women with endometriosis, suggesting that in addition to events at the site of endometriosis, systemic factors may play a role in the progression of endometriosis.
A decrease in cell-mediated immunity has also been observed in rhesus monkeys with spontaneous endometriosis (Dmowski et al, 1981) . For monkeys, the in vivo reactivity to the intradermal injection of autologous endometrial antigens and the in vitro lymphocyte proliferation in response to the same autologous endometrial antigens were significantly reduced (Dmowski and Radwanska, 1984) . Furthermore, cytotoxicity assays using peripheral lymphocytes and autologous 51 Cr-labeled endometrial cells as target cells demonstrated significantly reduced activity in endometriotic monkeys (Steele et al, 1984) . Based on these observations, it has been suggested that deficiencies in humoral and cellular immune parameters and increased activity of the peritoneal parameters system may be partly responsible for the progression of endometriosis.
Recently, Rier et al. (1993a) reported that the incidence of endometriosis in rhesus monkeys correlated with TCDD ingestion and its severity was dose dependent. In addition, Gerhard and Runnebaum (1992) reported that women with endometriosis tended to have higher blood levels of the higher chlorinated polychlorinated biphenyls (PCB) congeners. Since TCDD and PCB are both halogenated aromatics, and several lines of evidence confirm that a common receptor-mediated mechanism exists (Safe, 1990 (Safe, , 1994 , a possible relationship may exist between PCB ingestion and endometriosis. We recently completed a reproduction study (Arnold etal, 1993a (Arnold etal, ,b, 1995 wherein rhesus monkeys ingested graded dosages of PCB (Aroclor 1254) that were comparable to PCB exposure levels reported for specific human subpopulations (Dillon etal, 1981; Kriess, 1985; Lione, 1988) . Three of the first four monkeys that were euthanized had endometriosis and were from groups that ingested PCB. These data and relevant literature were reviewed and evaluated as to whether a relationship between PCB ingestion and endometriosis existed under the conditions of our study.
MATERIAL AND METHODS
The composition, acclimation, predosing evaluation, and monitoring of the monkeys have been described (Arnold et al, 1993a,b) , as were the source, purity, and composition of the Aroclor 1254 used (Mes et al, 1989; Arnold et al., 1990) . Briefly, 80 test monkeys (Macaca mulatto) were randomly distributed across four rooms and five test groups (i.e., 20 monkeys/room and 16 monkeys/dose group). The monkeys received daily dosages of 0, 5, 20, 40, or 80 fig of Aroclor 1254/kg body weight/day; which were designated as dose groups A, B, C, D, and E, respectively. The daily PCB dose was provided in a gelatin capsule containing corn oil and glycerol, which the monkeys self ingested.
As only 9 of the 80 monkeys were born in captivity, the remaining monkeys' ages were estimated . Their average estimated age at the time of study initiation was 11.5 ± 4.3 years (±standard deviation). Each monkey's known/estimated age is listed in Table 1 . For orientation purposes, the study was divided into phases:
1. Prebreeding phase-37 months. Dosing was initiated (March 21, 1983 ) and 90% of the treated monkeys attained a satisfactory qualitative pharmacokinetic steady state regarding the concentration of PCB in their adipose tissue. Four females (FC009, FD029, FD111, and FE107) became moribund and were euthanized (Table 1) .
2. Breeding phase-25 months. During this phase, FA053, FA089, FC061, FE057, and FEO83 became moribund and were euthanized; FE045 and FE139 died unexpectedly (Table 1) . Laparoscopic examinations, conducted randomly, were added to the original protocol as a consequence of the prebreeding pathological findings. The gynecologist (P. Claman) evaluating and defining the laparoscopic findings (American Fertility Society, 1985 ; also see Buttram, 1985) was not aware of the monkeys' test status.
3. Postbreeding phase-8 months. 4. (a) Depletion study-43 months. Twelve monkeys, three each from groups A, B, C, and D, were randomly selected and their PCB dosing was discontinued. Periodic blood, fat, and fecal samples were obtained for PCB congener analysis . These monkeys were necropsied during the 44th month, (b) Necropsy of nondepletion monkeys-6 months.
The following is a brief description of two methods used to investigate effects on the immune system during the prebreeding phase.
Antibodies to sheep red blood cells. Monkeys were intravenously administered an immunizing dose of SRBC in physiologic saline on Days 1, 8, and 15. Antibody (IgM) titers to SRBC were determined on Days 1 (preimmunization), 7, 14, and 21 postimmunization using the microplate hemolytic complement assay (Tryphonas et al, 1989 (Tryphonas et al, , 1991a . The titer was defined as the reciprocal of the highest dilution showing 50% hemolysis. Results are presented as the mean expressed as log 2 (titers/10) ± SD.
Natural killer cell activity. The NK cell activity of the effector cells (E: monocyte-depleted peripheral blood leukocytes isolated by Ficoll-Hypaque gradient centrifugation) was determined using a 4-hr "Cr release assay and the K562 cell line as the target (T) cells (Tryphonas et al, 1991b 3 (8) 2 (12) 1 (14) 1 2(7) 4(6) 6(8) 2 (7) 2 (8) 2 (12) 2 (5) 1 (17) 1 (16) Sept. 21, 1989 May 8, 1989 Oct. 6, 1987 June 5, 1989 Aug. 18, 1989 April 30, 1987 April 27, 1989 Nov. 20, 1992 May 18, 1989 Oct. 20, 1989 Feb. 20, 1991 Aug. 14, 1989 with Endometriosis Mar. 19, 1987 Sept. 19. 1989 May 12. 1989 April 17, 1989 Sept. 11, 1989 Aug. 24, 1989 Nov. 25. 1992 Aug. 22. 1989 June 7, 1989 Nov. 20, 1992 Oct. 18. 1989 Sept. 21, 1989 Aug. 16, 1989 Nov. 25, 1992 Oct. 8, 1985 June 13, 1989 June 9, 1989 Gynecological findings Arnold et al., 1993a) . Birth date refers to the outcome of the last pretest impregnation.
'' Laparocscopies undertaken during April-June 1988 were conducted by P. Claman, M.D., F.R.C.S., using the scoring system of the American Fertility Society (1985; also see Buttram, 1985) . NP, not performed. ' It is suggested that this lesion produced adhesions which were evaluated as endometrial adhesions when the laparoscopy was performed.
1 SAID, simian-acquired immunodeficiency sydrome.
* Abdominal scar was found-Cesarian?
STATISTICAL METHODOLOGY
A two-way analysis of variance model was used to compare the average estimated ages at the start of the study for females diagnosed with or without endometriosis at the time of necropsy. This model was also used to evaluate various immunological measures for females with or without endometriosis. The Cochran-Armitage test (Fleiss, 1981) was used to test whether there was an increasing linear doserelated trend in the incidence rates of endometriosis. For those females diagnosed with endometriosis, the Jonckheere-Terpstra test (Hollander and Wolfe, 1973, p. 120) was used to test for an increasing dose-related trend in severity levels. Fisher's exact test was used to compare the incidence of endometriosis between suppliers and to compare the incidence of endometriosis between the 71 feral females versus the 9 females born in captivity. For each of the immunological parameters, t test comparisons were carried out between the groups of monkeys with or without endometriosis within each test group (groups A, B, C, D, and E). Table 1 contains historical and study data germane to the issue of PCB treatment and factors which may be associated with endometriosis.
RESULTS
When the nondepletion monkeys were necropsied, 57 monkeys were available: Group A, 11 monkeys; B, 13; C, 11; D, 11; E, 11. Previously, 3 monkeys from groups A, B, C, and D had been randomly selected for the depletion study during which FA 157 was euthanized and the remaining 11 monkeys were necropsied. Table 2 contains a summary of the microscopically confirmed incidence of endometriosis for all of the study monkeys. The incidence of endometriosis was greatest in the control and high-dose groups, while the severity was somewhat less in the group E monkeys. A statistical analysis of these data did not indicate a doserelated trend regarding the incidence (p = 0.253) or the severity of the endometrial lesions (p = 0.808).
A statistical analysis of the average estimated ages of those monkeys with and without endometriosis was undertaken and there was no indication that the average estimated age for these two groups of monkeys was significantly different (p = 0.155).
The study monkeys were acquired from two major sources and three minor sources (Table 1) . Their respective incidence of endometriosis was 27.8, 24.1, and 33.3%. A statistical analysis of these data did not suggest that the presence of endometriosis was different among suppliers (p = 0.805). Interestingly, none of the 9 test monkeys born in captivity had endometriosis but 22 of the 71 feral monkeys had endometriosis. Based on Fisher's exact test, there was evidence of a significant difference in the incidence of endometriosis between these two groups (feral vesus laboratory) of monkeys {p = 0.046).
Results of the immunological testing of these monkeys have been reported previously (Tryphonas et al, 1988 (Tryphonas et al, ,1989 (Tryphonas et al, , 1991a . Statistically significant findings included: a doserelated decrease in anti-SRBC titers and a dose-related enhancement in the NK cell activity at the 75:1 E:T cell ratio.
Comparison of the mean anti-SRBC titers between monkeys with or without endometriosis within each test group did not reveal any statistically significant differences except for the group E monkeys, wherein a statistically significant increase in anti-SRBC titers was noted in the monkeys with endometriosis compared to those without. Studies were carried out to ascertain whether any correlation existed between the presence of endometriosis and NK cell activity, but they did not produce any conclusive evidence for such an association (data not presented). For the other parameters investigated, including the levels of tumor necrosis factor, interleukin-1, and thymosin al and 04 (Tryphonas et al., 1991b) , no statistically significant differences between monkeys with or without endometriosis were evident. Immunological investigations related to cell-mediated autoimmune responses or lymphocyte proliferation tests using autologous endometrial antigens were not undertaken.
DISCUSSION
When three of the first four euthanized monkeys were found to have endometriosis and to have received PCB, it appeared the PCB treatment and endometriosis might be associated. The extent of the disease had previously been described by Campbell et al. (1985 Campbell et al. ( , 1986 . Subsequently, Rock and Markham (1992) , discussing the pathogenesis of endometriosis, stated that "two unrelated studies in which the immune system was suppressed in rhesus monkeys, by proton radiation (Wood etal, 1983 ; incidence: controls 1/11, 9.1%; proton exposed 38/93,40.9%), and by polychlorinated biphenyls (Campbell et al., 1985) , endometriosis developed more frequently than in controls." Similarly, Dmowski et al. (1989 Dmowski et al. ( , 1990 , Dmowski (1991) , Anonymous (1993) , Rier et al. (1993a) , De Marco (1994) , and Holloway (1994) have cited Campbell et al. (1985) to support a relationship between PCB, immunological changes, and endometriosis.
The prevalence of endometriosis in rhesus monkeys varies from less than 1% to greater than 33% (DiGiacomo and McCann, 1970; MacKenzie et al, 1972; Seibold and Wolf, 1973; DiGiacomo, 1977; McClure, 1979; Wood et al, 1983; Lindberg and Busch, 1984; Fanton and Golden, 1991) . However, these figures are questionable as the studied populations were often reproductive culls or diseased monkeys; the initial stages of endometriosis may not interfere with impregnation and pregnancy may result in complete resolu- Scoring system of Buttram (1985) . * Monkeys that were euthanized or died during the dosing phase of the study; i.e., prior to April 1989. "Monkeys necropsied upon termination of the dosing portion study; i.e., April-October 1989 ''Monkeys euthanized during or necropsied upon termination of the depletion study; i.e., April 1989 -December 1992 tion of endometriosis (Schenken et al, 1987) , as it does in women (Raible, 1981) ; the examination for endometriosis may not have been conducted with the same thoroughness; and none of the authors performed laparoscopic examinations. Laparoscopy has been defined as ' 'the technique par excellence (authors' emphasis) for the diagnosis of pelvic endometriosis" (Brosens etal, 1993) and as "the gold standard for definitive diagnosis of endometriosis" (Olive and Schwartz, 1993) .
The initial symptoms of endometriosis in humans have been reported to occur as early as 3 years after menarche (Goldstein et al, 1980; Hoshiai et al., 1993) . Menarche occurs in the rhesus monkey around 2.5 years of age (Hendrickx and Kraemer, 1970, van Wagenen, 1972; Foster, 1977; Rapisarda et al, 1983; Terasawa et al., 1984) . Trying to ascertain the time interval between menarche and endometriosis in monkeys may be biased without laparoscopic examinations. Rier et al. (1993a) , following a retrospective study of the pathological records, reported that endometriosis was not seen in their rhesus monkeys until they were at least 13 years of age. In an attempt to determine the age at which endometriosis may develop, 14 reports concerning spontaneous endometriosis in rhesus monkeys were found. Six gave no indication as to the monkey's age(s) (Fraser, 1929; Cary et al, 1982; LaRegina and Vogler, 1984; Pittaway et al, 1986; Dmowski et al, 1981; Sternfeld et al, 1988) , and 8 provided estimates of 8-25 years (Krohn, 1951; Scott et al, 1953; McCann and Myers, 1970; Davis, 1987; Howard et al, 1989; Saegusa, 1990; Fanton and Golden, 1991; Moody et al, 1991) . In our study, the youngest monkeys with endometriosis (FC061 and FE097) had an estimated age of 11 years. Regardless, these data suggest that the "latent period," i.e., the time from menarche until endometriosis was evident, appears to be approximately twice as long for the rhesus monkey versus humans. Several authors (McClure et al, 1969; Splitter et al, 1972; Wood et al, 1983; Fanton and Golden, 1991) have irradiated 1-to 3-year-old rhesus monkeys and reported latent periods of 5-8 years for endo-metriosis. As most of these authors waited until an abdominal mass was evident, it seems that endometriosis may have been detected sooner by laparoscopy. Since spontaneous endometriosis in rhesus monkeys has generally been in older females near the end of their reproductive capabilities (Wood et al, 1983) , it has been suggested that the irradiation of female monkeys accelerates the aging process Yochmowitz et al., 1985) . Also, irradiation may suppress local immune functions, resulting in the ' 'establishment' ' of endometriotic tissue.
Clinical signs of endometriosis in rhesus monkeys may include bouts of anorexia, weight loss, abdominal discomfort, dysmenorrhea, constipation, menstrual irregularities, and eventually abdominal masses may be evident MacKenzie and Casey, 1975; Yochmowitz et al., 1985; Fanton and Golden, 1991) . Untreated endometriosis is often life-threatening in monkeys due to the size and invasive nature of the abdominal mass(es) (Ruch, 1959; Schiffer et al, 1984; Schaerdel, 1986; Wood, 1991) . Fanton and Golden (1991) evaluated 80 monkeys with endometriosis and reported that 43% had a gradual weight loss, 35% had anorexia, 53% had a "space-occupying" abdominal mass, 89% had abnormal uterine or ovarian anatomy, 28% had constipation, and 15% had abnormal menstrual or flow irregularities. However, blood cell counts and serum biochemical profiles had no diagnostic value. For the 22 monkeys with endometriosis in our study, 36% had a weight loss and anorexia, 50% had palpable abdominal masses, 68% had abnormal menses, 18% displayed lethargy, and 14% vomited.
Frequent abdominal findings with endometriosis include extensive adhesions involving the descending colon (66%), uterus (51%), ovaries (81%), and urinary bladder (50%). Other pathological findings include endometrial cysts (73%) and multiple endometriomas in the omentum and mesentary (54%; Fanton and Wood, 1986) . For the 22 monkeys with endometriosis in our study, extensive adhesions involved the small bowel (41%), descending colon (41%), uterus (82%), ovaries (41%), Fallopian tube (14%), urinary bladder (41%), omentum (3%), and stomach (5%) and 22% had endometrial cysts. Rier et al. (1993a) fed 6-to 10-year-old female rhesus monkeys diets containing 5 or 25 ppt TCDD for 4 years.
[To facilitate comparison on a toxicity equivalency factor basis, Hong et al. (1993) therefore, our monkey's dose was a factor of (364/25) 14.56 more potent]. Ten years later Rier et al. found a statistically significant (p < 0.05) increased incidence of endometriosis (controls, 2/6, 33%; low-dose TCDD, 3/7, 43%; high-dose TCDD, 5/7, 71%) in the treated groups and a statistically significant (p < 0.001) dose-related trend in severity, but the TCDD treatment did not lower the age at which the endometriosis was observed. As some PCB congeners and TCDD are thought to exert their toxicological effect via the same receptor-mediated mechanism (Safe, 1990 (Safe, , 1994 , it might be expected that PCB would increase the incidence and/or severity of endometriosis. The lack of any compelling support from our data for such a relationship might be attrib- uted to differences either in the dosing and observation periods or in our use of older monkeys. However, following a review of the pathological records pertaining to 83 monkeys used in studies undertaken at the Oregon Regional Primate Research Center by the late Dr. W. P. McNulty, Jr., Dr. M. K. Axthelm concluded that' 'these records do not support the notion of a bias for endometriosis in PCB-treated animals" (personal communication, 1995) . The monkeys in our study were acquired from five different sources of which none provided any indication as to their previous testing/treatment. It has been suggested that previous testing may be associated with the observed endometriosis (Moore, 1993) . However, there was no statistical difference in the incidence of endometriosis among monkeys from the different sources/suppliers (p = 0.805).
Hill (1992), Dmowski et al. (1991) , and Rier et al. (1993b) have suggested that immunological factors may play a role in the pathogenesis of endometriosis. While we have previously reported that some immunological parameters were affected by Aroclor 1254 ingestion (Tryphonas et al, 1988 (Tryphonas et al, , 1989 (Tryphonas et al, , 1991b , there does not appear to be justification for suggesting a link between PCB ingestion and endometriosis. The significance of the increased SRBC titers in group E monkeys with endometriosis compared to the group E monkeys without endometriosis was not apparent since the increase in antibody titers in the monkeys with endometriosis was statistically significant only at 21 days postimmunization (Table 3) . Furthermore, all of the monkeys in this group were immunosuppressed in comparison to the other groups including the controls (Tryphonas et al., 1988) . Consequently, the association between endometriosis and altered responses to SRBC cannot be made with certainty. However, our studies were not designed to investigate immune system-endometriosis interaction.
In conclusion, there was no compelling evidence to support a relationship between the daily dosages of PCBs used in our study, which were comparable with the exposure levels of specific human subpopulations to PCBs (Dillon et al, 1981; Kreiss, 1985; Lione, 1988) , and the incidence and severity of endometriosis or the selected immunological parameters. However, as previously reported , a statistical analysis of the reproduction data did provide evidence for a significant decreasing dose-related trend in conception rates and a significant dose-related trend in fetal mortality.
